首页 | 本学科首页   官方微博 | 高级检索  
检索        

沙利度胺联合化疗治疗实体瘤疗效观察
引用本文:杨兰平,黄汉生,陈慧华,傅军民,文玲波.沙利度胺联合化疗治疗实体瘤疗效观察[J].实用临床医药杂志,2011,15(9):71-72,83.
作者姓名:杨兰平  黄汉生  陈慧华  傅军民  文玲波
作者单位:广西省柳州市肿瘤医院,化疗科,广西,柳州,545006
摘    要:目的研究沙利度胺在晚期癌症患者中的辅助治疗作用。方法将已有病理确诊的63例晚期癌症患者随机分配至治疗组(n=31)与对照组(n=32)。治疗组患者予以沙利度胺联合化疗,对照组患者单纯予以化疗。观察两组的有效率及副反应。结果治疗组与对照组的有效率分别是54.8%与31.2%,2组间的有效率具有统计学差异(P<0.05)。2组间的副反应无统计学差异。结论在晚期癌症的治疗中采用沙利度胺联合化疗不但能提高疗效,而且并不增加化疗的不良反应。

关 键 词:沙利度胺  癌症  晚期  化疗  辅助治疗

Efficacy of Thalidomide combined with chemotherapy in the treatment of solid tumor
YANG Lan-ping,HUANG Han-sheng,CHEN Hui-hua,FU Jun-min,WEN Ling-bo.Efficacy of Thalidomide combined with chemotherapy in the treatment of solid tumor[J].Journal of Clinical Medicine in Practice,2011,15(9):71-72,83.
Authors:YANG Lan-ping  HUANG Han-sheng  CHEN Hui-hua  FU Jun-min  WEN Ling-bo
Institution:YANG Lan-ping,HUANG Han-sheng,CHEN Hui-hua,FU Jun-min,WEN Ling-bo(Liuzhou Cancer Hospital,Liuzhou,Guangxi,545006)
Abstract:Objective To investigate the adjunctive effect of Thalidomide on patients with advanced cancer.Methods Sixty-three patients with pathologically confirmed advanced cancer were randomly divided into treatment group(n=31) and control group(n=32).Patients in treatment group were administered chemotherapy plus thalidomide and those in control group were administered chemotherapy only.Response rate and side effect were observed.Results The response rate in treatment group and control group were 54.8% and 31.2%.Th...
Keywords:Thalidomide  cancer  advanced stage  chemotherapy  adjunctive therapy  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号